TABLE OF CONTENTS Practice Guidelines for the Diagnosis and Management of Cough. and diagnosis of cough type and severity are listed below.
|
|
- Harriet Long
- 5 years ago
- Views:
Transcription
1 TABLE OF CONTENTS 2006 Practice Guidelines for the Diagnosis and Management of Cough Guidelines for the Treatment of Sexually Transmitted Diseases P & T Committee Formulary Action Practice Guidelines for the Diagnosis and Management of Cough Introduction The Cardiopulmonary and Critical Care Journal (CHEST) published updated cough guidelines in January These guidelines updated information from a consensus panel report published in a 1998 supplement of CHEST. These revised guidelines serve as a template for the diagnosis and management of a variety of cough symptoms. Although the complete mechanisms of acute and chronic cough are unknown, the reflex is controlled by vagal afferent nerves in the visera. Coughing may be triggered by environmental factors, such as air pollution or smoke, or a medical condition, such as asthma. Most cough therapies target these cough triggers or underlying medical conditions in order to prevent or decrease cough symptoms. Depending on the severity of cough, a patient s overall quality of life may be greatly impacted. A summary of the treatment guidelines are presented below and a complete version is available at Diagnosis and Evaluation A patient s symptoms and possible underlying causes should be evaluated when he/she presents with a cough. Complete comprehensive diagnostic criteria do not exist for every cough etiology, so diagnosis may be primarily via exclusion. A history, physical examination, and possibly chest x-ray should be performed during the initial visit. If the cough s origin in undeterminable, the diagnosis may be based on a response, or non-response, to an empiric treatment. The first step in any treatment plan should be to eliminate or reduce exposure if a known respiratory irritant is identified. More specific examinations or diagnostic tests may be performed if a specific etiology, such as asthma or gastroesophageal reflux disease (GERD), is the suspected cause of the cough. Possible diagnostic procedures that may be useful in the evaluation and diagnosis of cough type and severity are listed below. Diagnostic Procedures Specific Etiology Determined Asthma Spirometry, bronchodilator reversibility, bronchial provocation challenge (BCP) Non-asthmatic eosinophilic bronchitis (NAEB) Evaluate for sputum eosinophilia Further Diagnostic Tools 24 hour esophageal ph monitoring Endoscopic or videofluoroscopic swallow evaluation Barium esophagram Sinus imaging High-resolution computed tomography (HRCT) Bronchoscopy Echocardiogram Environmental assessment In addition to the diagnostic procedures listed above, the 9 steps listed below may be utilized to help with the diagnosis process and future treatment. 1) For acute cough, determine if there is an underlying serious illness or a clinical manifestation of a less serious condition or due to environmental exposure. 2) For subacute cough, determine whether or not it is due to a recent infection. If not infectious, treat as if it were just a chronic cough. 3) For chronic cough, utilize empiric treatment in a step-wise sequential fashion targeting the most likely cause of the cough (reference the table below for further treatment recommendations). Initiate therapy using a first generation antihistamine/ decongestant. 1
2 4) For patients whose smoking is the cause of the cough, smoking cessation counseling should be performed. 5) For angiotensin-converting enzyme (ACE) inhibitor induced cough, the ACE inhibitor should be discontinued and replaced. 6) For chronic cough, for patients who fail treatment for upper airway cough syndrome (UACS), asthma should be considered next as the cause of the cough. Either BCP or a trial of an antiasthmatic drug may be used to determine if the patient is truly asthmatic. Ideally, the BCP should be performed before the initiation of oral corticosteroids and if the results of the test are positive, the empiric treatment guidelines found in the table should be initiated. 7) For patients who are negative for UACS and asthma, NAEB should be considered next as the cause for the cough. Either a sputum test for eosinophils or a trial of corticosteroids may be used to test for UACS. 8) For patients negative for UACS, asthma, and NAEB, GERD should be considered next as the cause for the cough. 9) For patients whose cough remains undiagnosed after all of the above steps are followed, a referral to a pulmonologist should be made. Special Populations There are some populations whose cough often requires special attention and unique management strategies. Patients presenting with conditions including: oral-pharngeal dysphagia, habit, tic, psychogenic, unexplained cough (formally idiopathic cough), or cough resulting from peritoneal dialysis should be referred to a physician or specialist to optimally manage their underlying medical symptoms and resultant cough. Immunocompromised patients presenting with cough must be evaluated slightly different than the general population. In addition to the criteria discussed for evaluation, CD4+ lymphocyte counts should be taken to help facilitate treatments decisions. Pediatric patients are another special population whose treatment and diagnosis may be slightly different than the general population. During a child s assessment, more in depth evaluations are often necessary to ensure proper diagnosis. For chronic cough, chest radiograph and spirometry should be performed in older children. The child should be evaluated to see if concurrent disease states such as asthma, cystic fibrosis (CF) or bronchietasis are present that have gone previously undiagnosed. A child will often present with a chronic cough as the first sign of some disease states like asthma. If a child presents with a chronic dry cough and is suspected of having asthma, they should be started on a 2 to 4 week beclomethasone or budesonide trial, and a response to treatment should be evaluated. If a chronic wet cough is observed, a 10 day antimicrobial regimen is recommended. As with adults, if a specific respiratory irritant is identified, it should be withdrawn along with the possibly of starting additional therapies. Other adult treatments (as highlighted in the table) and over-the-counter (OTC) medications are not recommended to be empirically started in children without further evaluation by a healthcare provider. Treatment Treatment is most commonly initiated empirically, based on the cough s presentation. The purpose of treatment is to decrease cough symptoms and, if possible, identify and treat any underlying causes for the condition. Side effects of any therapy should always be minimized while maximizing a patient s quality of life. If an underlying cause for the cough is identified as drug-induced, the offending drug should be discontinued. When the cough is attributed to environmental exposure to agents such as cigarette smoke, life style modifications should be implemented and the offending agent should be removed. Dietary restrictions may provide some relief in patients with GERD and physical therapy, such as chest physiotherapy, may help relive some symptoms in patients with cough secondary to bronchiectasis. In general, antibiotics are not recommended for cough, as cough is seldom of bacterial origin. Conditions which may warrant the use of antibiotics include whooping cough, acute exacerbation of chronic bronchitis, CF, bacterial bronchiolitis, and diffuse panbronchiolitis. Other infections that may cause cough, such as tuberculosis, should be treated following recommendations outlined in the respective treatment guidelines. In conjunction with the antibiotics, additional therapies, as listed in the table, may be utilized to help manage cough symptoms in these patients. For patient s whose cough does not qualify for antibiotic treatment, specific treatment recommendations are listed in the table. Within the table, some therapies are listed as refractive treatments or last-line agents. If listed as refractive, the other agents listed prior to that treatment should be tried first and if the patient is not responsive, then the refractive agent may be initiated. Surgeries are currently available for patients with GERD (antireflux surgery) and some types of bronchiectasis, but these are considered to be the last resort after all other treatments have failed. Additionally, a surgery recommendation may be given to patients with a cough secondary to the diagnosis of a lung tumor. 2
3 Table. Treatment Recommendations for Cough Etiology of Cough Treatment Recommendations Chronic upper airway cough secondary to rhinosinus disease or the common cold asthma GERD or other reflux disorders acute bronchitis chronic bronchitis Chronic cough due to nonasthmatic eosinophilic bronchitis (NAEB) bronchiectasis First generation antihistamine/decongestant: brompheniramine and sustained release pseudoephedrine Inhaled bronchodilator Inhaled corticosteroid (ICS) Leukotriene receptor antagonist (refractive patient) Short course (1 to 2 weeks) of an oral corticosteroids followed by ICS (refractive patient) Anti-reflux (acid suppressive) medications: proton pump inhibitor Life-style and dietary modifications Prokinetic therapy (refractive patient) With wheezing: ß 2 -agonist bronchodilator Short term antitussive agents Acute exacerbation: use of antibiotics is recommended along with short acting ß 2 - agonists and ipratropium bromide; oral corticosteroids may also be given (10-15 days) Stable patients with chronic bronchitis may be treated with: Short acting ß 2 -agonists Ipratropium bromide Theophylline ICS with long acting ß 2 - agonists Short term, centrally acting antitussives (dextromethorphan or codeine) ICSs Oral corticosteroids (refractive to ICS) Bronchodilators Antibiotics for acute exacerbations Chronic cough due to nonbronchiectatic suppurative airway disease Post infectious cough lung tumor Chronic cough due to chronic interstitial pulmonary disease Antibiotics for bacterial causes Oral corticosteroids and ICS for patients with inflammatory bowel disease Inhaled ipratropium Inhaled corticosteroids (refractive to ipratropium) Short term prednisone (severe patients) Centrally acting antitussives: codeine or dextromethorphan (when all other therapies fail) Centrally acting antitussives: such as hydrocodone Limited oral corticosteroids on an individual basis ICS therapy should follow oral corticosteroid therapy in patients with cough secondary to sarcoidosis Reference: American College of CHEST Physicians. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 2006;129(suppl):1S-22S. Guidelines for the Treatment of Sexually Transmitted Diseases In August 2006, the Centers for Disease Control and Prevention (CDC) published an update to the 2002 practice guidelines on the treatment of sexually transmitted diseases (STDs). Sexually transmitted diseases are among the most frequently reported infectious diseases in the United States. These guidelines are meant to assist physicians and health care professionals in their treatment and diagnosis, as well as improve prevention strategies. A summary of the recommended treatment regimens for common STDs is presented below. Genital Herpes Herpes Simplex Virus (HSV)-Type 1 and Type 2: Painful vesicular or ulcerative lesions on the genitals First episode: Acyclovir 400 mg PO TID for 7-10 days; or Acyclovir 200 mg PO five times daily for 7-10 days; or Famciclovir 250 mg PO TID for 7-10 days; or Valacyclovir 1 g PO BID for 7-10 days Suppressive therapy for recurrent infection: Acyclovir 400 mg PO BID; or Famciclovir 250 mg PO BID; or 3
4 Valacyclovir 500 mg PO daily; or Valacyclovir 1 g PO daily Episodic therapy for recurrent infection: Acyclovir 400 mg PO TID for 5 days; or Acyclovir 800 mg PO BID for 5 days; or Acyclovir 800 mg PO TID for 2 days; or Famciclovir 125 mg PO BID for 5 days; or Famciclovir 1g PO BID for 1 day; or Valacyclovir 500 mg PO BID for 3 days; or Valacyclovir 1 g PO daily for 5 days Symptomatic sex partners should be treated with the same regimens as above. Asymptomatic sex partners should receive typespecific serologic testing for HSV infection. Genital Warts Human Papilloma Virus Type 6 and 11: Flat, papular growths on the genital mucosa Majority of infections are asymptomatic External genital warts: Podofilox 0.5% solution or gel, applied BID for 3 days, followed by 4 days of no therapy. This cycle may be repeated up to 4 times; or Imiquimod 5% cream, applied at bedtime, 3 times per week for up to 16 weeks. Examination to assess the presence of genital warts Syphilis Systemic disease caused by T. pallidum Primary infection: ulcer or chancre at infection site Secondary infection: skin rash, mucocutaneous lesions, or swelling of lymph nodes Tertiary infection: cardiac or ophthalmic complications, auditory abnormalities, or gummatous lesions Latent infection: positive serologic tests without clinical symptoms Neurosyphilis: cognitive dysfunction, motor or sensory deficits, ophthalmic or auditory symptoms, cranial nerve palsies, and signs or symptoms of meningitis Primary and secondary syphilis: Benzathine penicillin G 2.4 million units IM in a single dose Tertiary syphilis: Benzathine penicillin G 7.2 million units, divided into 3 doses of 2.4 million units IM, each administered at 1- week intervals Early latent syphilis without CSF involvement: Benzathine penicillin G 2.4 million units IM in a single dose Late latent syphilis or latent syphilis of unknown duration: Same regimen as tertiary syphilis Neurosyphilis: Aqueous crystalline penicillin G million units IV per day, administered in 3 divided doses every 4 hours or continuous infusion, for days Treat presumptively if sexual contact occurred within 90 days of diagnosis of primary, secondary, or early latent syphilis. Treat presumptively when sexual contact occurred > 90 days of diagnosis of primary, secondary, or early latent syphilis and serologic tests are not available immediately or opportunity for follow-up is uncertain. Chancroid H. ducreyi infection Painful genital ulcer, negative HSV test and no evidence of T.pallidum in ulcer exudate, swelling of the glands or lymph nodes in the groin region Ceftriaxone 250 mg IM in a single dose; or Ciprofloxacin 500 mg PO BID for 3 days; or Erythromycin base 500 mg PO TID for 7 days Treat if sexual contact occurred within 10 days of onset of symptoms in partner. Nongonococcal Urethritis C. trachomatis, U. urealyticum, or M. genitalium infection Urethral inflammation, mucopurulent or purulent discharge, painful urination, or urethral itching Asymtomatic infections are common Nongonococcal urethritis: Doxycycline 100 mg PO BID for 7 days Recurrent and persistent urethritis: Metronidazole 2 g PO in a single dose + azithromycin 1 g PO in a single dose Evaluate and treat if sexual contact occurred within 60 days preceding diagnosis in partner. Testing for gonorrhea and chlamydia is encouraged. Cervicitis Typically C. trachomatic or N. gonnorhoeae infection; however, in a majority of cases no organism is isolated Purulent or mucopurulent cervical discharge, and intermenstrual vaginal bleeding Presumptive treatment: Doxycycline 100 mg PO BID for 7 days Test for gonorrhea, chlamydia, and trichomoniasis and treat accordingly if infection is present. Partner and patient should refrain from sexual intercourse for 7 days. 4
5 Chlamydia C. trachomatis infection Asymptomatic infections are common in males and females Sequelae include pelvic inflammatory disease, ectopic pregnancy, and infertility Doxycycline 100 mg PO BID for 7 days Evaluate and treat if sexual contact occurred within 60 days preceding onset of symptoms and diagnosis. If sexual contact occurred >60 days prior to onset of symptoms and diagnosis, treat only recent partner. Gonococcal Infections N. gonnorhoeae infection Asymptomatic infections are common among women Uncomplicated gonococcal infections of the cervix, urethra, and rectum*: Ceftriaxone 125 mg IM in a single dose; or Cefixime 400 mg PO in a single dose; or Ciprofloxacin 500 mg PO in a single dose; or Ofloxacin 400 mg PO in a single dose; or Levofloxacin 250 mg PO in a single dose Uncomplicated gonococcal infection of the pharynx*: Ceftriaxone 125 mg IM in a single dose; or Ciprofloxacin 500 mg in a single dose *If chlamydial infection is not ruled out, all regimens should include concomitant treatment for chlamydia. Gonococcal conjunctivitis: Ceftriaxone 1 g IM in a single dose Gonococcal bacteremia: Ceftriaxone 1 g IM or IV every 24 hours, up to 48 hours after improvement begins. Therapy may be switched to one of the following regimens to complete 1 week of antibiotic treatment: Cefixime 400 mg PO BID; or Ciprofloxacin 500 mg PO BID; or Ofloxacin 400 mg PO BID; or Levofloxacin 500 mg PO daily Gonococcal meningitis: Ceftriaxone 1-2 g IV Q12 for days Gonococcal endocarditis: Ceftriaxone 1-2 g IV Q12 for 4 weeks Evaluate and treat for gonorrhea and chlamydia if sexual contact occurred within 60 days preceding onset of symptoms and diagnosis. Always treat most recent partner, even if sexual contact occurred > 60 days preceding onset of symptoms Bacterial Vaginosis Thin, white vaginal discharge with a fishy odor Metronidazole 500 mg PO BID for 7 days; or Metronidazole gel, 0.75%, one full applicator (5 g) intravaginally, once daily for 5 days; or Clindamycin cream, 2%, one full applicator (5 g) intravaginally daily at bedtime for 7 days Treatment not recommended. Trichomoniasis T. vaginalis infection Females: may be asymptomatic or present with diffuse, foul-smelling, yellow-green vaginal discharge with vulvar irritation Males: may be asymptomatic or present with urethral inflammation, mucopurulent or purulent discharge, painful urination, or urethral itching Metronidazole 2 g PO in a single dose Treat with either of the above regimens. Instruct patient and partner to avoid sexual intercourse until therapy is completed or symptoms are resolved. Pelvic Inflammatory Disease Infection may be caused by any one of the following organisms: N. gonorrhoeae, C. trachomatis, G. vaginalis, H. influenzae, S. agalactiae, cytomegalovirus, M. hominis, U. urealyticum, or M. genitalium Abnormal bleeding, pelvic or lower abdominal pain, painful sexual intercourse, abnormal vaginal discharge, and fever Women may also be asymptomatic Parenteral Treatment: Cefotetan 2 g IV Q12 for 24 hours + doxycycline 100 mg PO or IV Q12 for 14 days; or Ceftoxitin 2 g IV Q6 for 24 hours + doxycycline 100 mg PO or IV Q12 for 14 days; or Oral Treatment: Levofloxacin 500 mg PO daily for 14 days + metronidazole 500 mg PO BID for 14 days; or Ofloxacin 400 mg PO BID for 14 days + metronidazole 500 mg PO BID for 14 days Treat if sexual contact occurred within 60 days preceding the onset of symptoms Reference: Centers for Disease Control and Prevention; Sexually transmitted diseases treatment guidelines: MMWR Recomm Rep 2006;55:
6 P&T Committee Formulary Action Additions Sildenafil - Restricted to treatment of pulmonary hypertension Deletions Varicella Zoster Immuneglobulin Diatrizoate meglumine (Hypaque) Triamcinolone diacetate (Aristocort) Papain-urea-chlorophyllin copper complex (Panafil) topical spray Authors: Megan Szmajda, PharmD candidate, class of 2008; Lauryn Tierney, PharmD candidate, class of 2008 Editor: Maria G. Tanzi, PharmD 6
Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More informationSexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
More informationTimby/Smith: Introductory Medical-Surgical Nursing, 9/e
Timby/Smith: Introductory Medical-Surgical Nursing, 9/e Chapter 62: Caring for Clients With Sexually Transmitted Diseases Slide 1 Epidemiology Introduction Study of the occurrence, distribution, and causes
More informationSexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System
Sexually Transmitted Infections in the Adolescent Population Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System STI in the Adolescent High school students nationwide, 34.2% were
More informationSEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)
SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5) BACTERIAL VAGINOSIS 1 clindamycin cream 2 Cleocin Vaginal Cream 2% vaginal cream Adults: 1 applicatorful at bedtime for 7 days metronidazole
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationSyphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference
Sexually Transmitted Diseases Family Medicine Board Review Course March 26, 2012 Ronald H. Goldschmidt, MD Reference Centers for Disease Control and Prevention Guidelines for Treatment of Sexually Transmitted
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationDermatologist Venereologist MD, PhD
Vassiliki Mousatou Dermatologist Venereologist MD, PhD Genital warts Genital herpes Syphilis Gonococcal and no gonococcal urethritis HIV Hepatitis B and C Also: Lymphogranuloma venereum and Granuloma
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationSTI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research
Teodora Wi Geneva, 28 August 2017 STI Treatment Guidelines Teodora Wi Training Course in Sexual and Reproductive Health Research 2017 Twitter @HRPresearch 1 STI treatment guidelines Neisseria gonorrhoeae
More informationDrugs for UTIs and STDs. Dr.Vishaal Bhat Associate Professor MMMC Manipal
Drugs for UTIs and STDs Dr.Vishaal Bhat Associate Professor MMMC Manipal Classification of UTI s Clinical: Asymptomatic (98%) Symptomatic (1-2%) Anatomical: Lower tract dis: asymptomatic bacteriuria and
More informationSTIs- REVISION. Prof A A Hoosen
STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex
More informationGUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS
WHO/HIV_AIDS/2001.01 WHO/RHR/01.10 Original: English Distr.: General GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS World Health Organization Copyright World Health Organization 2001.
More informationSTD UPDATE 2017 FSACOFP CONVENTION
STD UPDATE 2017 FSACOFP CONVENTION L. Michael Waters, Jr, DO Adjunct Clinical Assistant Professor of Family Medicine LECOM-Bradenton Clinical Assistant Professor of Family Medicine PCOM- Georgia DISCLOSURES
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationSelassie AW (DBBE) 1. Overview 12 million incident cases per year $10 billion economic impact More than 25 organisms.
Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 12 Sexually Transmitted Diseases Learning Objectives 1. Review the epidemiology of sexually Transmitted Diseases 2. Assess the personal
More information20. VAGINITIS AND SEXUALLY TRANSMITTED DISEASES 5. Allison L. Diamant, MD, MSPH, and Eve Kerr, MD, MPH
20. VAGINITIS AND SEXUALLY TRANSMITTED DISEASES 5 Allison L. Diamant, MD, MSPH, and Eve Kerr, MD, MPH The approach to developing quality indicators for vulvovaginitis and sexually transmitted diseases
More informationR eview. Cough: Controversies and Consensus Brian s Case. Acute Cough
R eview Cough: Controversies and Consensus 2011 Copyright Not for Sale or Commercial Distribution Irvin Mayers, MD, FRCPC Unauthorised use prohibited. Authorised users can download, display, view and print
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationAlberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2008
Alberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2008 General for STI Given the current rise in all STI in Alberta, it is appropriate to assess for risk
More informationWhat Bugs You? A Sexually Transmitted Infection Review
What Bugs You? A Sexually Transmitted Infection Review KATIE DESIMONE, PHARM.D. Disclosures I have no financial affiliations with any of the products or therapies discussed in this presentation Objectives
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Afferent nerves, interactions of, in cough, 20 21 Airway, eosinophilic inflammation of, 124 narrowing of, in asthma, 126 protection of, terms
More informationREPRODUCTIVE TRACT INFECTIONS
REPRODUCTIVE TRACT INFECTIONS State-of-the-Art 02.10.1998 Dr Saloney Nazeer Department of Gynaecology & Obstetrics Geneva University Hospital CLASSIFICATION OF RTIs STDs Non-STDs - infections which result
More informationEmerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More information½ of all new infections are among people aged although this age group represents <25% of the sexually experienced population.
Impact Almost 20 million - newly diagnosed STD s/sti s each year. $16 billion cost of treating STI s ½ of all new infections are among people aged 15-24 although this age group represents
More informationSexually transmitted infections
Sexually transmitted infections Dr Caroline CHARLIER-WOERTHER Université Paris Descartes Paris, France Learning objectives Counsel patients about the risk of STD Know how to diagnose and treat a sexuallytransmitted
More informationINTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management
INTRAUTERINE DEVICES AND INFECTIONS Tips for Evaluation and Management Objectives At the end of this presentation, the participant should be able to: 1. Diagnose infection after IUD placement 2. Provide
More informationCough: Make It Easy. Kreetha Thammakumpee Respiratory and Respiratory Critical Care Medicine Faculty of Medicine, Prince of Songkla University
Cough: Make It Easy Kreetha Thammakumpee Respiratory and Respiratory Critical Care Medicine Faculty of Medicine, Prince of Songkla University Cough: definition Acute < 3 wk Subacute 3-8 wk Chronic cough
More informationSeveral of the most common STDs are often asymptomatic. Asymptomatic
What Are STDs? Several of the most common STDs are often asymptomatic. Asymptomatic Individuals show no symptoms, or the symptoms are mild and disappear after the onset of the infection Common STDs There
More informationan inflammation of the bronchial tubes
BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious
More informationSYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization
WHO COLLABORATING CENTRE FOR RESEARCH IN HUMAN REPRODUCTION Hôpitaux Universitaires de Genève SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization Dr SALONEY NAZEER Department of Gynaecology
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationSEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS
SEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS Sarah Garwood MD, Assistant Professor of Pediatrics, Washington University Elizabeth Fox MD, Pediatric Resident, St Louis Children s Hospital STDS IN ADOLESCENTS
More informationSyphilis Technical Instructions for Civil Surgeons
National Center for Emerging and Zoonotic Infectious Diseases Syphilis Technical Instructions for Civil Surgeons Joanna J. Regan, MD, MPH, FAAP Medical Officer Medical Assessment and Policy Team Immigrant,
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationSexually Transmitted Diseases. Ch 24
Sexually Transmitted Diseases Ch 24 Statistics THERE ARE CURRENTLY 65 MILLION PEOPLE LIVING WITH INCURABLE STDs IN THE U.S. THERE ARE 15 MILLION NEW CASES REPORTED EACH YEAR SOURCE: CDC, 2000 REPORTS WHY
More informationAdvances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol
Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing
More informationMYTHS OF STIs True or False
MYTHS OF STIs True or False 1. Most people with an STD experience painful symptoms. 2. Birth control pills prevent the spread of STDs. 3. Douching will cure and STD. 4. Abstinence is the best way to prevent
More informationSEXUALLY TRANSMITTED DISEASES
SEXUALLY TRANSMITTED DISEASES Kaya Süer MD, Near East University Faculty of Medicine Infectious Diseases and Clinical Microbiology True or false 1. Most people with an STD experience painful symptoms.
More informationPodcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43
Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National
More information4/6/17 UNPRECEDENTED HIGH. Shelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annualmore than 1.5 million
More informationSTDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
More informationCHAPTER 26 - Microbial Diseases of the Urinary and Reproductive System
CHAPTER 26 - Microbial Diseases of the Urinary and Reproductive System Introduction The urinary system regulates the chemical composition of the blood and excretes nitrogenous waste. The reproductive system
More informationcontinuing education for pharmacists
continuing education for pharmacists Volume XXXV, No. 10 Sexually Transmitted Diseases: An Update on Treatment Guidelines Karen L. Kier, PhD, MSc, R.Ph., BCPS, BCACP, CTTS, Professor of Clinical Pharmacy,
More informationLTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS
LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS LTASEX.INFO! IN AIDS is a treatable complication of advanced HIV infection.
More informationHAVE YOU RECENTLY MOVED? PLEASE NOTIFY US.
W-F Professional Associates, Inc. 400 Lake Cook Rd., Suite 207 Deerfield, IL 60015 847-945-8050 June 2007 Review of Sexually Transmitted Diseases 707-000-07-006-H01 FLORIDA PHARMACISTS---Be sure to provide
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationShelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual more than 1.5 million
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More information8/20/18. Objectives. STI Presentations. Chlamydia Gonorrhea. Herpes Simples Virus
Objectives Distinguish the differential diagnosis of STI. What are the STI that are visible above the waistline Recognize the signs of STI versus rash When to refer. Shelagh Larson RNC, WHNP, NCMP STI
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationGynaecology. Pelvic inflammatory disesase
Gynaecology د.شيماءعبداألميرالجميلي Pelvic inflammatory disesase Pelvic inflammatory disease (PID) is usually the result of infection ascending from the endocervix causing endometritis, salpingitis, parametritis,
More informationMethodology and Grading of the Evidence for the Diagnosis and Management of Cough. ACCP Evidence-Based Clinical Practice Guidelines
Methodology and Grading of the Evidence for the Diagnosis and Management of Cough ACCP Evidence-Based Clinical Practice Guidelines Douglas C. McCrory, MD, MHS; and Sandra Zelman Lewis, PhD Objectives:
More informationALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES
ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES A. Screening Page Chlamydia and Gonorrhea 1 HIV 1 Syphilis 1 Genital Herpes 2 Hepatitis A 2 Hepatitis B 2 Hepatitis
More informationManagement that provides continuity of care for women
Management that provides continuity of care for women If women are diagnosed with reproductive tract infection, prompt treatment should be instituted according to the WHO guidelines. Though it may be preferred
More informationSTDs. Lesson 5.1. By Carone Fitness. Sexually Transmitted Diseases
Lesson 5.1 STDs By Carone Fitness The Silent Epidemic An epidemic is an outbreak of an infectious disease that affects a large population. Epidemics have afflicted people since the beginning of time, not
More informationCASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY
MHD II, Session 6, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6 Friday, MARCH 18, 2016 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis
More informationIndex. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.
Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,
More informationSexually Transmitted Infections
Sexually Transmitted Infections STI Director/ Centers for Disease Control Overview Definition of STIs: What are they? Transmission: How are they spread? Types of infection: -Bacterial (Chlamydia, LGV,
More information11/15/2017. Highgate Private Hospital (Royal Free London NHS Foundation Trust) Causes of chronic cough
A whistle stop of Chronic Cough For 10min consultations.. Dr Dean Creer Consultant Chest Physician (MBChB, FRCP) Highgate Private Hospital (Royal Free London NHS Foundation Trust) E: drcreer.pa@gmail.com(secretary)
More informationChapter 25 Notes Lesson 1
Chapter 25 Notes Lesson 1 The Risk of STIs 1) What is a sexually transmitted disease (STD)? Referred to as a sexually transmitted infection (STI) infectious diseases spread from person to person through
More informationSEXUALLY TRANSMITTED DISEASES (INFECTIONS)
SEXUALLY TRANSMITTED DISEASES (INFECTIONS) HIV/AIDS - TRANSMISSION Sexual intercourse Anal, oral, & vaginal Multiple partners Sharing needles Mother to infant Born or breast milk Blood transfusions Open
More informationSexually Transmitted Diseases Treatment Guidelines, 2015
Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015 Sexually Transmitted Diseases Treatment Guidelines, 2015 U.S. Department of Health and Human Services Centers
More informationChlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationCOUGH. Jim Reid University of Otago Medical School Dunedin, New Zealand
COUGH Jim Reid University of Otago Medical School Dunedin, New Zealand COUGH One of five most common presentations in general practice Remember the law of probability Common things occur commonly But
More informationVaginitis. Antibiotics Changes in hormone levels due to pregnancy, breastfeeding, or menopause Douching Spermicides Sexual intercourse Infection
WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Vaginitis Vaginitis is an inflammation of a woman s vagina. It is one of the most common reasons why women see their health care providers.
More informationRecommended Preventive Care Snapshot
Preventive Care Recommendations For quick reference, this snapshot provides a general list of preventive care recommendations that you and your family members may need to consider. It also describes what
More informationHow is it transferred?
STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationChallenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A
Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple
More informationQuick Study: Sexually Transmitted Infections
Quick Study: Sexually Transmitted Infections Gonorrhea What is it: A bacterial infection of the genitals, anus, or throat. How common: The CDC estimates 820,000 people in the United States get Gonorrhea
More informationShelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annual more than 1.5 million
More informationChancroid Table of Contents
Subsection: Chancroid Page 1 of 8 Chancroid Table of Contents Chancroid Fact Sheet Subsection: Chancroid Page 2 of 8 Chancroid (Haemophilus ducreyi) Overview (1,2) For a more complete description of chancroid,
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases What are they? Infections that spread from person to person through sexual contact More than 25 known STDs Most of the time those who have them may not realize it, hard to
More informationMicrobial Diseases of the Urinary and Reproductive Systems
PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R 26 Microbial Diseases of the Urinary and Reproductive Systems 1 Structure and Function of the
More informationSTI s. (Sexually Transmitted Infections)
STI s (Sexually Transmitted Infections) Build Awareness In Canada and around the world, the trend is clear: sexually transmitted infections (STIs) are on the rise. One of the primary defenses in the fight
More informationChronic Cough. Dr Peter George Consultant Respiratory Physician Royal Brompton and Harefield Hospitals
Chronic Cough Dr Peter George Consultant Respiratory Physician Royal Brompton and Harefield Hospitals Overview Common causes of chronic cough Important diagnoses not to miss How to investigate a cough
More informationCase 1. Case 1. Physical exam
11/13/2012 Case 28 year-old woman Complains of very painful lesions in vulvar area Increasing severity since 4 days Pain aggravated by urination She has a slight fever and also complains of headache and
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationDisclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationSTD Prevention Among Youth
STD Prevention Among Youth Jody Pierce Glover New Beginnings Emer S. Smith, MPH Maine Center for Disease Control & Prevention In Today s Talk... Maine Learning Results: Education Content Areas Health Behaviors
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationSexually Transmitted Diseases:
Sexually Transmitted Diseases: Diagnosis and Management Department of Internal Medicine, Division of Infectious Diseases University of New Mexico A 21 year old woman comes to your clinic asking to be checked
More informationMicrobial Diseases of the Urinary and Reproductive Systems
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University Packet #14 Chapter #24 Microbial Diseases of the Urinary and Reproductive Systems Structures of the Urinary
More informationCommon Sexually Transmitted Diseases: Diagnosis and Treatment 2.0 Contact Hours Presented by: CEU Professor
Common Sexually Transmitted Diseases: Diagnosis and Treatment 2.0 Contact Hours Presented by: CEU Professor 7 www.ceuprofessoronline.com Copyright 8 2007 The Magellan Group, LLC All Rights Reserved. Reproduction
More information9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before
George Walton, MPH, CPH, MLS(ASCP) CM STD Program Manager Bureau of HIV, STD, and Hepatitis September 15, 2015 1 1) Discuss the changing epidemiology of syphilis in Iowa; 2) Explore key populations affected
More informationSexually Transmitted Diseases. David T. Bearden, Pharm.D. Clinical Associate Professor
Sexually Transmitted Diseases David T. Bearden, Pharm.D. Clinical Associate Professor STDs. Gonorrhea Syphilis Chlamydia PID Genital Herpes HPV (genital warts) Trichomoniasis Guidelines MMWR August 4,
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationUpdate on management of respiratory symptoms. Dr Farid Bazari Consultant Respiratory Physician Kingston Hospital NHS FT
Update on management of respiratory symptoms Dr Farid Bazari Consultant Respiratory Physician Kingston Hospital NHS FT Topics The common respiratory symptoms Cough: causes, diagnosis and therapy Update
More information